Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding VCNX, Q2 2026
No superinvestor reported holding VCNX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Vaccinex, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2024 (view filing)4:30 PM ET | Aug 9 | 4 days | Friedberg Albert and 1 otherDirector, 10% Owner | PPurchase | +100 | $4.51 | +$451 | 0.0%780.6K after | |
| Aug 7, 2024 (view filing)4:04 PM ET | Aug 5-6 | 2 days | Friedberg Albert and 1 otherDirector, 10% Owner | PPurchase | +6.41K | $4.74 | +$30.3K | +0.8%780.5K after | 2 lots |
| Aug 2, 2024 (view filing)4:05 PM ET | Aug 1 | 1 day | Friedberg Albert and 1 otherDirector, 10% Owner | PPurchase | +11.7K | $4.72 | +$55.2K | +1.5%774.1K after | |
| Aug 1, 2024 (view filing)4:05 PM ET | Jul 31 | 1 day | Friedberg Albert and 1 otherDirector, 10% Owner | PPurchase | +200.0K | $6.15 | +$1.23M | +35.6%762.4K after | 3 lots |
| May 31, 2024 (view filing)4:31 PM ET | May 29-30 | 2 days | Friedberg Albert and 1 otherDirector, 10% Owner | PPurchase | +1.82K | $5.07 | +$9.21K | +0.3%562.4K after | 2 lots |
| Apr 22, 2024 (view filing)4:33 PM ET | Apr 19 | 3 days | Friedberg Albert and 1 otherDirector, 10% Owner | PPurchase | +282 | $4.73 | +$1.33K | +0.1%560.6K after | |
| Dec 28, 2023 (view filing) | Dec 26 | 2 days | Van Strydonck, Gerald E.Director | SSale | −3.15K | $0.72 | −$2.27K | −100.0%0 after | |
| Dec 12, 2023 (view filing) | Dec 8 | 4 days | Van Strydonck, Gerald E.Director | SSale | −1.33K | $0.67 | −$893.78 | −29.8%3.15K after | |
| Oct 5, 2023 (view filing)4:31 PM ET | Oct 3 | 2 days | Zauderer Maurice and 1 otherPresident and CEO | PPurchase | +500.0K | $1.00 | +$500.0K | +104.3%979.6K after | |
| Oct 5, 2023 (view filing)4:31 PM ET | Oct 3-4 | 2 days | Zauderer Maurice and 1 otherPresident and CEO | PPurchase | +10.0K | $0.9515 | +$9.52K | +82.5%22.1K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Vaccinex, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding VCNX in 13F filings for Q2 2026.